Last10K.com

Carefusion Corp (CFN) SEC Filing 10-K Annual report for the fiscal year ending Monday, June 30, 2014

Carefusion Corp

CIK: 1457543 Ticker: CFN
Exhibit 99.1
            
3750 Torrey View Ct
San Diego, CA 92130
www.carefusion.com


FOR IMMEDIATE RELEASE
Contacts:
Media: Troy Kirkpatrick
              (858) 617-2361
              troy.kirkpatrick@carefusion.com
Investors: Jim Mazzola
(858) 617-1203
jim.mazzola@carefusion.com

CAREFUSION REPORTS FOURTH QUARTER AND FISCAL 2014 RESULTS

Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 percent.

Fourth quarter GAAP diluted earnings per share (EPS) from continuing operations increased 37 percent to $0.67, or up 44 percent to $0.79 on an adjusted basis.

Fiscal 2014 GAAP diluted EPS from continuing operations increased 13 percent to $1.96, or up 11 percent to $2.36 on an adjusted basis.

Company expects fiscal 2015 adjusted diluted EPS in the range of $2.60 to $2.75; Announces new $750 million share repurchase authorization.


SAN DIEGO, Aug. 7, 2014 - CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2014, provided guidance for fiscal 2015, its longer-term outlook through fiscal 2017 and announced a new $750 million share repurchase authorization.
“With every business growing in the fourth quarter, we had a very strong finish to the fiscal year and created good momentum for fiscal 2015,” said Kieran Gallahue, chairman and CEO. “Our solid organic revenue growth demonstrates the value our products bring to health care facilities and patients, even in times of increasing financial pressures for U.S. hospitals.
“Procedural Solutions provided strong results across all businesses in the fourth quarter and for the year, with the Vital Signs acquisition performing well. Medical Systems had a very robust quarter, led by record growth from Infusion and another quarter of record committed contracts from Dispensing.”


The following information was filed by Carefusion Corp (CFN) on Thursday, August 7, 2014 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Carefusion Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Carefusion Corp.

Continue

Assess how Carefusion Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Carefusion Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Consolidated Statements Of Stockholders' Equity
Acquisitions
Acquisitions (detail)
Acquisitions (narrative) (details)
Acquisitions (tables)
Borrowings
Borrowings (future Payments Of Long Term Obligations) (detail)
Borrowings (narrative) (detail)
Borrowings (phantom) (details)
Borrowings (schedule Of Borrowings) (detail)
Borrowings (tables)
Commitments And Contingencies
Commitments And Contingencies (future Minimum Rental Payments For Operating Leases) (detail)
Commitments And Contingencies (narrative) (detail)
Commitments And Contingencies (tables)
Description Of Business And Summary Of Significant Accounting Policies
Description Of Business And Summary Of Significant Accounting Policies (detail)
Description Of Business And Summary Of Significant Accounting Policies (policies)
Discontinued Operations And Assets Held For Sale
Discontinued Operations And Assets Held For Sale (narrative) (detail)
Earnings Per Share
Earnings Per Share (antidilutive Securities) (detail)
Earnings Per Share (reconciliation Of Basic And Diluted Earnings Per Share) (detail)
Earnings Per Share (tables)
Earnings Per Share Earnings Per Share (narrative) (details)
Employee Savings Plan
Employee Savings Plan (narrative) (detail)
Fair Value Measurements
Fair Value Measurements (narrative) (detail)
Fair Value Measurements (schedule Of Financial Assets And Liabilities That Are Measured At Fair Value On Recurring Basis) (detail)
Fair Value Measurements (tables)
Fair Value Measurements Fair Value Measurement (schedule Of Changes In Contingent Consideration Liability) (details)
Financial Instruments
Financial Instruments (narrative) (detail)
Financial Instruments (schedule Of Fair Value Of Assets And Liabilities Related To Derivative Instruments) (detail)
Financial Instruments (schedule Of Gain (loss) Recognized In Earnings For Fair Value Hedges) (detail)
Financial Instruments (schedule Of Notional Amount Of Fair Value Hedges Outstanding) (detail)
Financial Instruments (schedule Of Notional Amount Of Outstanding Cash Flow Hedges) (detail)
Financial Instruments (schedule Of Unsettled Derivative Instruments And Associated Amount) (detail)
Financial Instruments (tables)
Financing Receivables
Financing Receivables (narrative) (detail)
Financing Receivables (schedule Of Change In Allowance For Credit Losses On Financing Receivables) (detail)
Financing Receivables (summary Of Credit Losses And Recorded Investment In Sales-type Leases) (detail)
Financing Receivables (tables)
Goodwill And Other Intangible Assets
Goodwill And Other Intangible Assets (narrative) (detail)
Goodwill And Other Intangible Assets (schedule Of Amortization Expense For Each Of Next Five Fiscal Years) (detail)
Goodwill And Other Intangible Assets (schedule Of Amortization Expense) (detail)
Goodwill And Other Intangible Assets (schedule Of Intangible Assets) (detail)
Goodwill And Other Intangible Assets (summary Of Changes In Carrying Amount Of Goodwill, Net Of Adjustments For Discontinued Operations) (detail)
Goodwill And Other Intangible Assets (tables)
Income Tax Components Of Deferred Tax Assets And Liabilities (detail)
Income Tax Income Taxes (narrative) (details)
Income Tax Income Taxes (schedule Of Income Taxes) (detail)
Income Tax Schedule Of Deferred Tax Assets And Liabilities (detail)
Income Tax Schedule Of Effective Income Tax Rate Reconciliation (detail)
Income Tax Schedule Of Income Before Income Tax, Domestic And Foreign (detail)
Income Tax Schedule Of Unrecognized Tax Benefit Roll Forward (detail)
Income Taxes
Income Taxes (tables)
Inventories
Inventories (schedule Of Inventories) (detail)
Inventories (tables)
Investments In Unconsolidated Entities
Investments In Unconsolidated Entities (details)
Investments In Unconsolidated Entities (tables)
Investments In Unconsolidated Entities Investments In Unconsolidated Entities (narrative) (details)
Leases
Leases (components Of Net Investment In Sales-type Leases) (detail)
Leases (future Minimum Lease Payments To Be Received Pursuant To Operating Leases) (detail)
Leases (future Minimum Lease Payments To Be Received Pursuant To Sales-type Leases) (detail)
Leases (products Under Operating Leases) (detail)
Leases (tables)
Product Warranties
Product Warranties (narrative) (detail)
Product Warranties (summary Of Changes In Carrying Amount Of Liability For Product Warranties) (detail)
Product Warranties (tables)
Property And Equipment
Property And Equipment (narrative) (detail)
Property And Equipment (schedule Of Property And Equipment) (detail)
Property And Equipment (tables)
Reclassifications Out Of Accumulated Other Comprehensive Income
Reclassifications Out Of Accumulated Other Comprehensive Income (details)
Reclassifications Out Of Accumulated Other Comprehensive Income (tables)
Restructuring And Acquisition Integration Charges
Restructuring And Acquisition Integration Charges (narrative) (detail)
Restructuring And Acquisition Integration Charges (schedule Of Current Restructuring Programs) (detail)
Restructuring And Acquisition Integration Charges (schedule Of Segment Restructuring Charges) (detail)
Restructuring And Acquisition Integration Charges (summary Of Restructuring And Acquisition Integration Charges) (detail)
Restructuring And Acquisition Integration Charges (tables)
Schedule Ii - Valuation And Qualifying Accounts
Schedule Ii - Valuation And Qualifying Accounts (detail)
Segment Information
Segment Information (narrative) (detail)
Segment Information (reconciliation Of Total Segment Operating Income To Consolidated Income Before Income Tax) (detail)
Segment Information (schedule Of Information About Reporting Segments) (detail)
Segment Information (schedule Of Revenue And Net Property And Equipment By Geographic Area) (detail)
Segment Information (schedule Of Revenue Information For Select Business Lines Within Each Of Segments) (detail)
Segment Information (tables)
Selected Quarterly Financial Data (summary Of Selected Quarterly Financial Data) (detail)
Selected Quarterly Financial Data (summary Of Selected Quarterly Financial Data) (parenthetical) (detail)
Selected Quarterly Financial Data (unaudited)
Selected Quarterly Financial Data (unaudited) (tables)
Share-based Compensation
Share-based Compensation (fair Value For Awards Granted) (detail)
Share-based Compensation (narrative) (detail)
Share-based Compensation (performance Target By Tranche) (detail)
Share-based Compensation (share-based Payment Activity) (detail)
Share-based Compensation (stock Option Activity) (detail)
Share-based Compensation (summary Of Restricted Stock Award) (detail)
Share-based Compensation (tables)
Share-based Compensation Share-based Compensation (performance Stock Unit Activity) (details)
Subsequent Events
Subsequent Events (details)
Ticker: CFN
CIK: 1457543
Form Type: 10-K Annual Report
Accession Number: 0001502823-14-000040
Submitted to the SEC: Mon Aug 11 2014 7:27:11 AM EST
Accepted by the SEC: Mon Aug 11 2014
Period: Monday, June 30, 2014
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cfn/0001502823-14-000040.htm